Artiva Biotherapeutics, Common Stock Technical Analysis
| ARTV Stock | 10.40 0.22 2.07% |
As of the 18th of December 2024, Artiva Biotherapeutics, shows the Downside Deviation of 6.24, mean deviation of 5.03, and Risk Adjusted Performance of 0.0395. Artiva Biotherapeutics, technical analysis gives you the methodology to make use of historical prices and volume patterns to determine a pattern that approximates the direction of the firm's future prices. Please confirm Artiva Biotherapeutics, variance and potential upside to decide if Artiva Biotherapeutics, is priced correctly, providing market reflects its regular price of 10.4 per share. Given that Artiva Biotherapeutics, has jensen alpha of 0.1963, we suggest you to validate Artiva Biotherapeutics, Common's prevailing market performance to make sure the company can sustain itself at a future point.
Artiva Biotherapeutics, Momentum Analysis
Momentum indicators are widely used technical indicators which help to measure the pace at which the price of specific equity, such as Artiva, fluctuates. Many momentum indicators also complement each other and can be helpful when the market is rising or falling as compared to ArtivaArtiva |
Artiva Biotherapeutics, Analyst Consensus
| Target Price | Advice | # of Analysts | |
| 21.25 | Strong Buy | 5 | Odds |
Most Artiva analysts issue ratings four times a year, at intervals of three months. Ratings are usually accompanied by a target price to helps potential investors understand Artiva stock's fair price compared to its market value. Analysts arrive at stock ratings after researching public financial statements of Artiva Biotherapeutics,, talking to its executives and customers, or listening to Artiva conference calls.
Artiva Biotherapeutics, technical stock analysis exercises models and trading practices based on price and volume transformations, such as the moving averages, relative strength index, regressions, price and return correlations, business cycles, stock market cycles, or different charting patterns.
Artiva Biotherapeutics, Technical Analysis
The output start index for this execution was one with a total number of output elements of sixty. The Average True Range was developed by J. Welles Wilder in 1970s. It is one of components of the Welles Wilder Directional Movement indicators. The ATR is a measure of Artiva Biotherapeutics, volatility. High ATR values indicate high volatility, and low values indicate low volatility.
Artiva Biotherapeutics, Trend Analysis
Use this graph to draw trend lines for Artiva Biotherapeutics, Common. You can use it to identify possible trend reversals for Artiva Biotherapeutics, as well as other signals and approximate when it will take place. Remember, you need at least two touches of the trend line with actual Artiva Biotherapeutics, price movement. To start drawing, click on the pencil icon on top-right. To remove the trend, use eraser icon.Artiva Biotherapeutics, Best Fit Change Line
The following chart estimates an ordinary least squares regression model for Artiva Biotherapeutics, Common applied against its price change over selected period. The best fit line has a slop of 0.06 , which may suggest that Artiva Biotherapeutics, Common market price will keep on failing further. It has 122 observation points and a regression sum of squares at 117.78, which is the sum of squared deviations for the predicted Artiva Biotherapeutics, price change compared to its average price change.About Artiva Biotherapeutics, Technical Analysis
The technical analysis module can be used to analyzes prices, returns, volume, basic money flow, and other market information and help investors to determine the real value of Artiva Biotherapeutics, Common on a daily or weekly bases. We use both bottom-up as well as top-down valuation methodologies to arrive at the intrinsic value of Artiva Biotherapeutics, Common based on its technical analysis. In general, a bottom-up approach, as applied to this company, focuses on Artiva Biotherapeutics, price pattern first instead of the macroeconomic environment surrounding Artiva Biotherapeutics,. By analyzing Artiva Biotherapeutics,'s financials, daily price indicators, and related drivers such as dividends, momentum ratios, and various types of growth rates, we attempt to find the most accurate representation of Artiva Biotherapeutics,'s intrinsic value. As compared to a bottom-up approach, our top-down model examines the macroeconomic factors that affect the industry/economy before zooming in to Artiva Biotherapeutics, specific price patterns or momentum indicators. Please read more on our technical analysis page.
| 2021 | 2022 | 2023 | 2024 (projected) | ROE | 0.81 | 0.41 | 0.17 | 0.16 | Income Quality | 0.21 | 0.86 | 1.65 | 1.73 |
Artiva Biotherapeutics, December 18, 2024 Technical Indicators
Most technical analysis of Artiva help investors determine whether a current trend will continue and, if not, when it will shift. We provide a combination of tools to recognize potential entry and exit points for Artiva from various momentum indicators to cycle indicators. When you analyze Artiva charts, please remember that the event formation may indicate an entry point for a short seller, and look at different other indicators across different periods to confirm that a breakdown or reversion is likely to occur.
| Cycle Indicators | ||
| Math Operators | ||
| Math Transform | ||
| Momentum Indicators | ||
| Overlap Studies | ||
| Pattern Recognition | ||
| Price Transform | ||
| Statistic Functions | ||
| Volatility Indicators | ||
| Volume Indicators |
| Risk Adjusted Performance | 0.0395 | |||
| Market Risk Adjusted Performance | 0.2173 | |||
| Mean Deviation | 5.03 | |||
| Semi Deviation | 6.12 | |||
| Downside Deviation | 6.24 | |||
| Coefficient Of Variation | 2368.8 | |||
| Standard Deviation | 6.68 | |||
| Variance | 44.64 | |||
| Information Ratio | 0.0321 | |||
| Jensen Alpha | 0.1963 | |||
| Total Risk Alpha | (0.26) | |||
| Sortino Ratio | 0.0344 | |||
| Treynor Ratio | 0.2073 | |||
| Maximum Drawdown | 32.08 | |||
| Value At Risk | (10.48) | |||
| Potential Upside | 10.28 | |||
| Downside Variance | 38.9 | |||
| Semi Variance | 37.43 | |||
| Expected Short fall | (5.47) | |||
| Skewness | 0.4434 | |||
| Kurtosis | 1.06 |
Additional Tools for Artiva Stock Analysis
When running Artiva Biotherapeutics,'s price analysis, check to measure Artiva Biotherapeutics,'s market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Artiva Biotherapeutics, is operating at the current time. Most of Artiva Biotherapeutics,'s value examination focuses on studying past and present price action to predict the probability of Artiva Biotherapeutics,'s future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Artiva Biotherapeutics,'s price. Additionally, you may evaluate how the addition of Artiva Biotherapeutics, to your portfolios can decrease your overall portfolio volatility.